Results summary | View all lists in L2L MDB | View all genes in D10AA.profile.u50 |
Reduced expression in XPC-defective fibroblasts, compared to normal fibroblasts, following treatment with cisplatin enrichment: 5.57-fold |
![]() |
![]() | |||||||||||
Probe ID | Name | G | T | D | X | E | P | R | C | S | ![]() |
![]() |
Description |
207001_X_AT | TSC22D3 | R | ![]() |
![]() |
TSC22 domain family, member 3 | ||||||||
208763_S_AT | TSC22D3 | R | ![]() |
![]() |
TSC22 domain family, member 3 | ||||||||
203140_AT | BCL6 | G | D | X | R | C | S | ![]() |
![]() |
B-cell CLL/lymphoma 6 (zinc finger protein 51) | |||
214166_AT | SDHB | T | E | ![]() |
![]() |
succinate dehydrogenase complex, subunit B, iron sulfur (Ip) | |||||||
212501_AT | CEBPB | G | D | X | P | R | ![]() |
![]() |
CCAAT/enhancer binding protein (C/EBP), beta |